Jenny Byrne

Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · Blood · 2011 · 196 citations · Full text

Medicine, Hematology, Oncology +15

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

Mark J. Levis, Mehdi Hamadani, Brent R. Logan et al. · Journal of Clinical Oncology · 2024 · 185 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

Charles Craddock, Nadira Jilani, Shamyla Siddique et al. · Biology of Blood and Marrow Transplantation · 2015 · 173 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

Charles Craddock, Aimee Jackson, Justin Loke et al. · Journal of Clinical Oncology · 2020 · 165 citations · Full text

Medicine, Oncology, Chemotherapy +14

De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trial

Fotios Polydoros, Jane F. Apperley, Dragana Milojković et al. · The Lancet Haematology · 2017 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17